WAP
TLSI icon

Wealthcare Advisory Partners’s TriSalus Life Sciences TLSI Stock Holding History

Wealthcare Advisory Partners’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-643,740
Closed -$4.49M – 1136
2025
Q4 		$4.49M Hold
643,740
– – 0.09% 200
2025
Q3 		$2.99M Hold
643,740
– – 0.06% 255
2025
Q2 		$3.51M Hold
643,740
– – 0.08% 205
2025
Q1 		$3.55M Hold
643,740
– – 0.1% 182
2024
Q4 		$3.23M Hold
643,740
– – 0.09% 188
2024
Q3 		$2.97M Buy
+643,740
New +$3.41M 0.08% 206

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Wealthcare Advisory Partners's TLSI Position: Q1 2026 in Review

Wealthcare Advisory Partners sold out of TriSalus Life Sciences (TLSI) in Q1 2026, closing a stake of 643,740 shares — an estimated $4.49M sold.

Wealthcare Advisory Partners first reported a position in TLSI in Q3 2024 and held it in 6 quarters. The position peaked at $4.49M in Q4 2025. 84 funds tracked by Wall St. Rank hold TLSI as of Q1 2026.

  • Wealthcare Advisory Partners reported no remaining TriSalus Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 643,740 TriSalus Life Sciences shares in Q1 2026, an estimated $4.49M.
  • Wealthcare Advisory Partners first reported a position in TriSalus Life Sciences in Q3 2024 and held it in 6 quarters.
  • Wealthcare Advisory Partners's TriSalus Life Sciences position peaked at $4.49M in Q4 2025.
  • 84 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q1 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q1 2026, filed 14 Apr 2026.